The industry is shifting away from acquisition-led growth toward site-level performance improvement. While selective M&A remains part of the playbook, it is no longer the primary driver of value creation.
DSOs are prioritizing:
Increasing revenue per site versus total network volume
Optimizing treatment mix toward higher-value services such as implants and orthodontics
Using performance data to identify missed diagnoses and close care gaps
Improving scheduling, case acceptance, and operational efficiency
Treatment mix optimization is proving especially impactful. Expanding higher-value procedures can improve margins without relying solely on volume growth, with implants remaining a key area of focus.